Perbedaan Lippo Karawaci Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Lippo Karawaci Tbk. diperdagangkan di Rp61 (kapitalisasi pasar 4,32 T, volume 24 jam 78,75 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Lippo Karawaci Tbk. jauh lebih besar — sekitar 26× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Lippo Karawaci Tbk. lebih aktif diperdagangkan (78,75 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LPKR | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 4,32 T | 166,01 M |
Volume | 78,75 jt | 324 rb |
Lot | 787,51 rb | 3,24 rb |
Perputaran | 4,81 M | 77,68 jt |
Harga Rata-rata | 61,05 | 239,75 |
Nilai Transaksi | 4,81 M | 77,68 jt |
Harga Ekuilibrium Indikatif | 61 | 240 |
Volume Ekuilibrium Indikatif | 28,62 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Selengkapnya di halaman LPKR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →